Aclarion Inc (ACON)

$7.35 -0.13 (-1.74%)
Market Cap 4.28M
Revenue (ttm) 50,000.00
Net Income (ttm) -6.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13,980.00%
Debt to Equity Ratio 0.00
Volume 13,800
Avg Vol 13,710
Day's Range N/A - N/A
Shares Out 582,000.00
Stochastic %K 7%
Beta 1.40
Analysts Sell
Price Target $22.00

Company Profile

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs whi...

Industry: Health Information Services
Sector: Healthcare
Phone: 833 275 2266
Address:
8181 Arista Place, Suite 100, Broomfield, United States
HouseOfTheDragons
HouseOfTheDragons Oct. 3 at 2:20 AM
Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Also watching for breakout: $ABVC $ACON $AIRE $AKAN -
1 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 1:26 AM
$AREB $SBEV $ACON $LGHL [
0 · Reply
tusambolo
tusambolo Oct. 1 at 10:59 AM
$ACON I am waiting for the pump before the dump, I just hope that wasn't it.
1 · Reply
DipnRiptrader
DipnRiptrader Sep. 30 at 3:07 PM
$ACON Well this duped me good. Needs news for volume.
1 · Reply
DipnRiptrader
DipnRiptrader Sep. 25 at 5:04 PM
$ACON added more today.
0 · Reply
brptrader
brptrader Sep. 25 at 12:12 PM
$ACON crickets...
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 25 at 10:41 AM
$ACON First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial By Aclarion, Inc. | September 25, 2025, 6:00 AM
0 · Reply
brptrader
brptrader Sep. 24 at 8:27 PM
$ACON definitely being a little bitch last 3 days
1 · Reply
The_Laugh_of_Wallstreet
The_Laugh_of_Wallstreet Sep. 23 at 5:17 PM
$ACON 80000$ volume
0 · Reply
DipnRiptrader
DipnRiptrader Sep. 23 at 5:12 PM
$ACON could have sold and reentered but thats just annoying when you know its going much higher
1 · Reply
Latest News on ACON
Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

Jun 24, 2025, 7:00 AM EDT - 3 months ago

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

May 20, 2025, 6:00 AM EDT - 4 months ago

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

May 12, 2025, 7:34 AM EDT - 5 months ago

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Apr 29, 2025, 6:00 AM EDT - 5 months ago

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Apr 23, 2025, 6:00 AM EDT - 5 months ago

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Apr 21, 2025, 6:00 AM EDT - 5 months ago

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Apr 9, 2025, 7:00 AM EDT - 6 months ago

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Apr 2, 2025, 6:00 AM EDT - 6 months ago

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Mar 31, 2025, 7:00 AM EDT - 6 months ago

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Aclarion Provides Shareholder Update

Mar 13, 2025, 9:25 AM EDT - 7 months ago

Aclarion Provides Shareholder Update

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Mar 6, 2025, 9:35 AM EST - 7 months ago

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Aclarion Announces First Commercial Agreement with Scripps Health

Mar 3, 2025, 6:00 AM EST - 7 months ago

Aclarion Announces First Commercial Agreement with Scripps Health

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Feb 20, 2025, 6:00 AM EST - 8 months ago

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Feb 11, 2025, 7:58 AM EST - 8 months ago

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Feb 6, 2025, 7:23 AM EST - 8 months ago

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Feb 4, 2025, 7:23 AM EST - 8 months ago

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Nov 21, 2024, 8:00 AM EST - 11 months ago

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Nov 14, 2024, 5:00 PM EST - 11 months ago

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 10, 2024, 7:00 AM EDT - 1 year ago

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Sep 27, 2024, 6:57 AM EDT - 1 year ago

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Sep 13, 2024, 8:30 AM EDT - 1 year ago

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Sep 12, 2024, 6:57 AM EDT - 1 year ago

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Sep 10, 2024, 6:57 AM EDT - 1 year ago

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

Sep 5, 2024, 6:57 AM EDT - 1 year ago

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Aug 29, 2024, 6:57 AM EDT - 1 year ago

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

Aug 21, 2024, 7:57 AM EDT - 1 year ago

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

Aug 15, 2024, 9:48 AM EDT - 1 year ago

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

Aclarion Announces First Commercial Agreement in Michigan

Aug 14, 2024, 8:08 AM EDT - 1 year ago

Aclarion Announces First Commercial Agreement in Michigan

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

Aug 13, 2024, 9:07 AM EDT - 1 year ago

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

Jul 9, 2024, 7:00 AM EDT - 1 year ago

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

Jun 26, 2024, 8:30 AM EDT - 1 year ago

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Jun 25, 2024, 8:30 AM EDT - 1 year ago

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Apr 25, 2024, 9:14 AM EDT - 1 year ago

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Aclarion Announces Closing of $3.0 Million Public Offering

Feb 27, 2024, 3:22 PM EST - 1 year ago

Aclarion Announces Closing of $3.0 Million Public Offering

Aclarion Announces Pricing of $3.0 Million Public Offering

Feb 26, 2024, 9:15 AM EST - 1 year ago

Aclarion Announces Pricing of $3.0 Million Public Offering

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Feb 5, 2024, 8:00 AM EST - 1 year ago

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Jan 22, 2024, 8:00 AM EST - 1 year ago

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Nov 27, 2023, 8:00 AM EST - 2 years ago

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

Nov 6, 2023, 8:00 AM EST - 2 years ago

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

Oct 25, 2023, 8:30 AM EDT - 2 years ago

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

Oct 24, 2023, 8:45 AM EDT - 2 years ago

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

Oct 23, 2023, 7:00 AM EDT - 2 years ago

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

Aug 25, 2023, 4:10 PM EDT - 2 years ago

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

Jun 14, 2023, 11:27 AM EDT - 2 years ago

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

Jun 8, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

May 30, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD

May 23, 2023, 7:30 AM EDT - 2 years ago

Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD

Aclarion, Inc. Announces Delayed 10-Q Filing

May 23, 2023, 7:00 AM EDT - 2 years ago

Aclarion, Inc. Announces Delayed 10-Q Filing

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts

May 19, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts

Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023

Apr 28, 2023, 11:20 AM EDT - 2 years ago

Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023

HouseOfTheDragons
HouseOfTheDragons Oct. 3 at 2:20 AM
Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Also watching for breakout: $ABVC $ACON $AIRE $AKAN -
1 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 1:26 AM
$AREB $SBEV $ACON $LGHL [
0 · Reply
tusambolo
tusambolo Oct. 1 at 10:59 AM
$ACON I am waiting for the pump before the dump, I just hope that wasn't it.
1 · Reply
DipnRiptrader
DipnRiptrader Sep. 30 at 3:07 PM
$ACON Well this duped me good. Needs news for volume.
1 · Reply
DipnRiptrader
DipnRiptrader Sep. 25 at 5:04 PM
$ACON added more today.
0 · Reply
brptrader
brptrader Sep. 25 at 12:12 PM
$ACON crickets...
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 25 at 10:41 AM
$ACON First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial By Aclarion, Inc. | September 25, 2025, 6:00 AM
0 · Reply
brptrader
brptrader Sep. 24 at 8:27 PM
$ACON definitely being a little bitch last 3 days
1 · Reply
The_Laugh_of_Wallstreet
The_Laugh_of_Wallstreet Sep. 23 at 5:17 PM
$ACON 80000$ volume
0 · Reply
DipnRiptrader
DipnRiptrader Sep. 23 at 5:12 PM
$ACON could have sold and reentered but thats just annoying when you know its going much higher
1 · Reply
brptrader
brptrader Sep. 23 at 2:48 PM
$ACON PS. Price targets dont mean shit..whish they would stop using them
0 · Reply
SofaKing_Nuts
SofaKing_Nuts Sep. 23 at 12:27 PM
$ACON low float rocket or a con?
1 · Reply
gapureau
gapureau Sep. 22 at 2:48 PM
$ACON Since Aclarion did not actually develop this technology but Licensed it from "Regents of the University of California", (who actually owns the patents) under an annual/earned Royalty agreement. The U.S. licensed patents that are currently issued start to expire between 2026 and 2029. Any news that they will be able to extend or renew any or all of these Patents??
1 · Reply
Putnik
Putnik Sep. 22 at 10:31 AM
$ACON let’s go!! $20!
0 · Reply
Gabriel5498
Gabriel5498 Sep. 22 at 9:57 AM
$ACON
0 · Reply
Twills08
Twills08 Sep. 21 at 2:16 PM
$ACON Keeping an eye here
0 · Reply
BullseyeStock
BullseyeStock Sep. 21 at 8:22 AM
BOXL- you got to put this one your watchlist for next week, super undervalued gem, catch it early before it goes parabolic.💎 BOXL 0 shares to borrow, no dilution issue, plenty of cash on hand plus assets. This is the type of tickers market is sending on 200-300%+ rally, don't miss it bulls $KAVL $ACON $EVTL $UAVS
0 · Reply
BullsEyePick
BullsEyePick Sep. 20 at 8:04 PM
Ticker BOXL has the same ingredients as past parabolic runners — but it’s still cheap.💎 Top watch next week. ✅ Zero borrow ✅ No dilution ✅ $30+ valuation case ✅ Next leg could be wild. Also watching. $SURG $ACON $MLSS $MLGO
0 · Reply
tmcLikeAndSubscribe
tmcLikeAndSubscribe Sep. 20 at 3:22 AM
The ultimate banger or $ACON ?
0 · Reply
Putnik
Putnik Sep. 20 at 12:34 AM
$ACON cool story see ya at $18 to $20
0 · Reply
Rayslch
Rayslch Sep. 20 at 12:31 AM
$ACON this is a scam people! look into mr. ness/bond and your see for yourself.
0 · Reply
The_Laugh_of_Wallstreet
The_Laugh_of_Wallstreet Sep. 19 at 7:14 PM
$ACON 10-18$ next week?
1 · Reply